Announced today the initiation of patient screening in a Stage 1 scientific trial of APD916.

Arena Pharmaceuticals initiates individual screening for phase 1 clinical trial of APD916 Arena Pharmaceuticals, Inc. announced today the initiation of patient screening in a Stage 1 scientific trial of APD916, a novel oral drug candidate uncovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy. There is a dependence on better tolerated, far better therapies for narcolepsy, narcolepsy with cataplexy especially, said William R . Shanahan, M.D., Arena’s Vice President and Chief Medical Officer. Based on preclinical data, we think that APD916 may substantially enhance the treatment of the potential orphan indications.

levitra online

And the producers of sun care products aren’t performing us any favors, he suggests, when their products block the very light rays that help our bodies to produce vitamin D in the skin. ‘Going out in to the sun does not really appear to matter much, if you don’t are outside the whole day perhaps,’ Wilson says, and ‘tanning beds can be used to get more supplement D, but they may not be safe. ‘ And food, on its own, may not offer more than enough support either. ‘Vitamin D is not high enough in cod liver oil, or just in milk products and pasture-fed meats. If one eats three or four cans of sardines per week, one will not need a supplement D supplement in most cases.’ He does not recommend consuming salmon, tuna, dark cod or any additional fish or seafood generally, because of the higher toxic mercury content.